Flagship Harbor Advisors LLC trimmed its position in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 47.7% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 6,317 shares of the exchange traded fund’s stock after selling 5,756 shares during the period. Flagship Harbor Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $770,000 at the end of the most recent reporting period.
A number of other hedge funds have also bought and sold shares of XBI. Capital A Wealth Management LLC bought a new stake in shares of SPDR S&P Biotech ETF during the second quarter valued at approximately $26,000. Davis Capital Management acquired a new position in SPDR S&P Biotech ETF in the third quarter worth approximately $35,000. Halbert Hargrove Global Advisors LLC acquired a new position in SPDR S&P Biotech ETF in the third quarter worth approximately $40,000. Barnes Dennig Private Wealth Management LLC purchased a new position in SPDR S&P Biotech ETF during the 4th quarter worth approximately $48,000. Finally, Premier Financial Group purchased a new position in SPDR S&P Biotech ETF during the 3rd quarter worth approximately $50,000.
SPDR S&P Biotech ETF Stock Performance
NYSEARCA XBI opened at $130.65 on Thursday. The firm’s 50 day moving average price is $125.11 and its two-hundred day moving average price is $119.10. SPDR S&P Biotech ETF has a twelve month low of $66.66 and a twelve month high of $133.27. The stock has a market cap of $7.96 billion, a price-to-earnings ratio of 11.47 and a beta of 0.91.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
See Also
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
